The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Glucose variability and mortality in patients with sepsis*
Open accessAbstract
OBJECTIVE: Treatment and prevention of hyperglycemia has been advocated for subjects with sepsis. Glucose variability, rather than the glucose level, has also been shown to be an important factor associated with in-hospital mortality, in general, critically ill patients. Our objective was to determine the association between glucose variability and hospital mortality in septic patients and the expression of glucose variability that best reflects this risk. DESIGN: Retrospective, single-center cohort study. SETTING: Academic, tertiary care hospital. PATIENTS: Adult subjects hospitalized for >1 day, with a diagnosis of sepsis were included. INTERVENTIONS: None. MEASUREMENTS: Glucose variability was calculated for all subjects as the average and standard deviation of glucose, the mean amplitude of glycemic excursions, and the glycemic lability index. Hospital mortality was the primary outcome variable. Logistic regression was used to determine the odds of hospital death in relation to measures of glucose variability after adjustment for important covariates. MAIN RESULTS: Of the methods used to measure glucose variability, the glycemic lability index had the best discrimination for mortality (area under the curve = 0.67, p < 0.001). After adjustment for confounders, including the number of organ failures and the occurrence of hypoglycemia, there was a significant interaction between glycemic lability index and average glucose level, and the odds of hospital mortality. Higher glycemic lability index was not independently associated with mortality among subjects with average glucose levels above the median for the cohort. However, subjects with increased glycemic lability index, but lower average glucose values had almost five-fold increased odds of hospital mortality (odds ratio = 4.73, 95% confidence interval = 2.6-8.7) compared with those with lower glycemic lability index. CONCLUSIONS: Glucose variability is independently associated with hospital mortality in septic patients. Strategies to reduce glucose variability should be studied to determine whether they improve the outcomes of septic patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988) · Biometrics · doi:10.2307/2531595 · Cited by 22,649
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
DEYO, R. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90133-8 · Cited by 10,452 · cited 2×
“We explored potential confounders, including patient demographics (age, race, gender, and insurance status), comorbidities included in the Charlson-Deyo score (20), the number of organ-failures, hypoglycemia and process of care variables (ICU admission, insulin administration and frequency of glucose monitoring, and c…”
BackgroundMethodIntensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Angus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503
Dellinger, R. P., Levy, M. M., Carlet, J. M., Bion, J., Parker, M. M., Jaeschke, R., Reinhart, K., Angus, D. C., Brun-Buisson, C., Beale, R., et al. (2008) · Intensive Care Medicine · doi:10.1007/s00134-007-0934-2 · Cited by 6,772
The epidemiology of sepsis in the United States from 1979 through 2000
Martin, G. S., Mannino, D. M., Eaton, S., & Moss, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022139 · Cited by 5,841
Intensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639 · cited 2×
“Targeting normoglycemia with the use of continuous insulin infusions (intensive insulin therapy [IIT]) improves outcomes in a selected group of critically ill patients (11, 12).”
BackgroundIntensive insulin therapy and pentastarch resuscitation in severe sepsis
Brunkhorst, F. M., Engel, C., Bloos, F., Meier-Hellmann, A., Ragaller, M., Weiler, N., Moerer, O., Gruendling, M., Oppert, M., Grond, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa070716 · Cited by 2,921
Monnier, L., Mas, E., Ginet, C., Michel, F., Villon, L., Cristol, J.-P., & Colette, C. (2006) · JAMA · doi:10.1001/jama.295.14.1681 · Cited by 2,444
Chiasson, J.-L., Josse, R. G., Gomis, R., Hanefeld, M., Karasik, A., Laakso, M., & for The STOP-NIDDM Trial Research Group (2003) · JAMA · doi:10.1001/jama.290.4.486 · Cited by 1,624
McCowen, K. C., Malhotra, A., & Bistrian, B. R. (2001) · Critical Care Clinics · doi:10.1016/s0749-0704(05)70154-8 · Cited by 1,170
Norhammar, A., Tenerz, Å., Nilsson, G., Hamsten, A., Efendíc, S., Rydén, L., & Malmberg, K. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09089-x · Cited by 1,112
Russell, J. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmra043632 · Cited by 1,048
Variability of Blood Glucose Concentration and Short-term Mortality in Critically Ill Patients
Egi, M., Bellomo, R., Stachowski, E., French, C. J., & Hart, G. (2006) · Anesthesiology · doi:10.1097/00000542-200608000-00006 · Cited by 854
Severe hypoglycemia in critically ill patients: risk factors and outcomes
Krinsley, J. S., & Grover, A. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000282073.98414.4b · Cited by 671
(2004) · Intensive Care Medicine · doi:10.1007/s00134-003-2121-4 · Cited by 638 · cited 1×
“Patients with sepsis, a manifestation of infection where systemic signs of inflammation are present and vital organ function may be impaired, are at greater risk of death than those suffering from uncomplicated infections (1).”
BackgroundIntermittent high glucose enhances apoptosis in human umbilical vein endothelial cells in culture
Risso, A., Mercuri, F., Quagliaro, L., Damante, G., & Ceriello, A. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.5.e924 · Cited by 425
National estimates of severe sepsis in United States emergency departments
Wang, H. E., Shapiro, N. I., Angus, D. C., & Yealy, D. M. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000277043.85378.c1 · Cited by 421
Stress-hyperglycemia, insulin and immunomodulation in sepsis
Marik, P. E., & Raghavan, M. (2004) · Intensive Care Medicine · doi:10.1007/s00134-004-2167-y · Cited by 419
Should minimal blood glucose variability become the gold standard of glycemic control?
Hirsch, I. B., & Brownlee, M. (2005) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2004.10.001 · Cited by 405
The Effect of Glucose Variability on the Risk of Microvascular Complications in Type 1 Diabetes
Kilpatrick, E. S., Rigby, A. S., & Atkin, S. L. (2006) · Diabetes Care · doi:10.2337/dc06-0293 · Cited by 377
Ryan, E. A., Shandro, T., Green, K., Paty, B. W., Senior, P. A., Bigam, D., Shapiro, A. M. J., & Vantyghem, M.-C. (2004) · Diabetes · doi:10.2337/diabetes.53.4.955 · Cited by 343
Glucose Measurement: Confounding Issues in Setting Targets for Inpatient Management
Dungan, K., Chapman, J., Braithwaite, S. S., & Buse, J. (2007) · Diabetes Care · doi:10.2337/dc06-1679 · Cited by 292
Self-citationPredisposing factors for hypoglycemia in the intensive care unit*
Vriesendorp, T. M., van Santen, S., DeVries, J. H., de Jonge, E., Rosendaal, F. R., Schultz, M. J., & Hoekstra, J. B. L. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000194536.89694.06 · Cited by 282
Evaluation of short-term consequences of hypoglycemia in an intensive care unit*
Vriesendorp, T. M., DeVries, J. H., van Santen, S., Moeniralam, H. S., de Jonge, E., Roos, Y. B. W. E. M., Schultz, M. J., Rosendaal, F. R., & Hoekstra, J. B. L. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000241155.36689.91 · Cited by 215
Intensive Insulin Therapy in Critical Care
Wilson, M., Weinreb, J., & Hoo, G. W. S. (2007) · Diabetes Care · doi:10.2337/dc06-1964 · Cited by 206
Weiser, M. A., Cabanillas, M. E., Konopleva, M., Thomas, D. A., Pierce, S. A., Escalante, C. P., Kantarjian, H. M., & O'Brien, S. M. (2004) · Cancer · doi:10.1002/cncr.20071 · Cited by 204
Pinto, D. S., Skolnick, A. H., Kirtane, A. J., Murphy, S. A., Barron, H. V., Giugliano, R. P., Cannon, C. P., Braunwald, E., & Gibson, C. M. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.03.052 · Cited by 181
Ali, N. A., O’Brien, J. M., Blum, W. G., Byrd, J. C., Klisovic, R. B., Marcucci, G., Phillips, G. S., Marsh, C. B., Lemeshow, S. A., & Grever, M. R. (2007) · Cancer · doi:10.1002/cncr.22777 · Cited by 98
Self-citationAhrens, C. L., Barletta, J. F., Kanji, S., Tyburski, J. G., Wilson, R. F., Janisse, J. J., & Devlin, J. W. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000186746.64572.8a · Cited by 92
A global perspective on the epidemiology of sepsis
Moss, M., & Martin, G. S. (2004) · Intensive Care Medicine · doi:10.1007/s00134-004-2182-z · Cited by 69
Enteral nutrition versus parenteral nutrition—the risks and benefits
Jeejeebhoy, K. N. (2007) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0797 · Cited by 57
The Effect of Glucose Variability on the Risk of Microvascular Complications in Type 1 Diabetes
Monnier, L., Colette, C., Leiter, L. A., Ceriello, A., Markolf Hanefeld, E., Owens, D. R., Tajima, N., Tuomiletho, J., Davidson, J. A., & On Behalf of the PGR Group (2006) · Diabetes Care · doi:10.2337/dc06-1594 · Cited by 56
Influence of insulin on glucose metabolism and energy expenditure in septic patients
Rušavý, Z., Šrámek, V., Lacigová, S., Novák, I., Tesinsky, P., & Macdonald, I. A. (2004) · Critical Care · doi:10.1186/cc2868 · Cited by 46
Hypoglycemia in Hospitalized Adult Patients without Diabetes
Mendoza, A., Kim, Y. N., & Chernoff, A. (2005) · Endocrine Practice · doi:10.4158/ep.11.2.91 · Cited by 45
McCowen, K. C., Ling, P. R., Ciccarone, A., Mao, Y., Chow, J. C., Bistrian, B. R., & Smith, R. J. (2001) · Critical Care Medicine · doi:10.1097/00003246-200104000-00032 · Cited by 44
Vriesendorp, T. M., DeVries, J. H., Hulscher, J. B. F., Holleman, F., van Lanschot, J. J. B., & Hoekstra, J. B. L. (2004) · Critical Care · doi:10.1186/cc2970 · Cited by 37
Molecular biology: A timely tool for further unraveling the “diabetes of stress”
den Berghe, G. V. (2001) · Critical Care Medicine · doi:10.1097/00003246-200104000-00052 · Cited by 13
Cited by
Dungan, K. M., Braithwaite, S. S., & Preiser, J.-C. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60553-5 · Cited by 1,431
Self-citationJacobi, J., Bircher, N., Krinsley, J., Agus, M., Braithwaite, S. S., Deutschman, C., Freire, A. X., Geehan, D., Kohl, B., Nasraway, S. A., et al. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e3182653269 · Cited by 571
Handelsman, Y., Mechanick, J. I., Blonde, L., Grunberger, G., Bloomgarden, Z. T., Bray, G. A., Dagogo-Jack, S., Davidson, J. A., Einhorn, D., Ganda, O., et al. (2011) · Endocrine Practice · doi:10.4158/ep.17.s2.1 · Cited by 513
Sepsis: A Review of Advances in Management
Rello, J., Valenzuela-Sánchez, F., Ruiz-Rodriguez, M., & Moyano, S. (2017) · Advances in Therapy · doi:10.1007/s12325-017-0622-8 · Cited by 443
Krinsley, J. S., Egi, M., Kiss, A., Devendra, A. N., Schuetz, P., Maurer, P. M., Schultz, M. J., van Hooijdonk, R. T., Kiyoshi, M., Mackenzie, I. M., et al. (2013) · Critical Care · doi:10.1186/cc12547 · Cited by 369
Self-citation
Metadata
- Authors
- Ali, N. A., OʼBrien, J. M., Dungan, K., Phillips, G., Marsh, C. B., Lemeshow, S., Connors, A. F., & Preiser, J.-C.
- Venue
- Critical Care Medicine
- Published
- 2008-08
- Volume
- 36
- Issue
- 8
- Pages
- 2316-2321
- ISSN
- 0090-3493 (ISSN-L)
- OpenAlex
- W2045596475
- Cited by
- 432
- References
- 38
- FWCI
- 25.71
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.